Lazard Asset Management LLC Neuro Pace Inc Transaction History
Lazard Asset Management LLC
- $58.2 Billion
- Q1 2025
A detailed history of Lazard Asset Management LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,099 shares of NPCE stock, worth $40,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,099
Previous 3,407
9.04%
Holding current value
$40,658
Previous $38,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NPCE
# of Institutions
94Shares Held
29.9MCall Options Held
1.8KPut Options Held
300-
Kck Ltd. Tortola, D85.27MShares$69.2 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$44.7 Million1.3% of portfolio
-
Polar Capital Holdings PLC London, X02.97MShares$39 Million0.24% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.61MShares$34.2 Million2.65% of portfolio
-
Morgan Stanley New York, NY2.53MShares$33.2 Million0.0% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $326M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...